JP5583689B2 - ピペラジン誘導体の調製プロセス - Google Patents
ピペラジン誘導体の調製プロセス Download PDFInfo
- Publication number
- JP5583689B2 JP5583689B2 JP2011541615A JP2011541615A JP5583689B2 JP 5583689 B2 JP5583689 B2 JP 5583689B2 JP 2011541615 A JP2011541615 A JP 2011541615A JP 2011541615 A JP2011541615 A JP 2011541615A JP 5583689 B2 JP5583689 B2 JP 5583689B2
- Authority
- JP
- Japan
- Prior art keywords
- solvent
- monocyclic
- optionally substituted
- bicyclic
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title description 6
- 150000004885 piperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 238000000034 method Methods 0.000 claims description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 125000002950 monocyclic group Chemical group 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000003444 phase transfer catalyst Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000002619 bicyclic group Chemical group 0.000 claims description 6
- -1 tetra-n-butylammonium halide Chemical class 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 5
- 150000005621 tetraalkylammonium salts Chemical group 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000012044 organic layer Substances 0.000 claims description 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 3
- CKDWPUIZGOQOOM-UHFFFAOYSA-N Carbamyl chloride Chemical compound NC(Cl)=O CKDWPUIZGOQOOM-UHFFFAOYSA-N 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 3
- 125000001589 carboacyl group Chemical group 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 125000003944 tolyl group Chemical group 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000012467 final product Substances 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 3
- GIAOVZPOOUDJDR-UHFFFAOYSA-N 4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]-1-(dimethylamino)cyclohexane-1-carboxamide Chemical compound C1CC(N(C)C)(C(N)=O)CCC1CCN1CCN(C=2C(=C(Cl)C=CC=2)Cl)CC1 GIAOVZPOOUDJDR-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000012453 solvate Substances 0.000 description 2
- 0 C*(*(C)N)C(N)=O Chemical compound C*(*(C)N)C(N)=O 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101150049660 DRD2 gene Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- NBYQXBYMEUOBON-UHFFFAOYSA-N carbamothioyl chloride Chemical compound NC(Cl)=S NBYQXBYMEUOBON-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000007730 finishing process Methods 0.000 description 1
- QMEZUZOCLYUADC-UHFFFAOYSA-N hydrate;dihydrochloride Chemical compound O.Cl.Cl QMEZUZOCLYUADC-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical group CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical class C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Description
‐ 任意にアリール基で置換された直鎖または分岐したC1−6アルキル、または
‐ 1−3個の二重結合を含むC2−7のアルケニル基、または
‐ 任意に1またはそれ以上のC1−6アルコキシ、トリフルオロ−C1−6アルコキシ、C1−6アルコキシカルボニル、C1−6アルカノイル、アリール、C1−6アルキルチオ、ハロゲン、またはシアノ基で置換された単環、二環または三環アリール基、または
‐ 任意に置換された単環、二環または三環シクロアルキル基、または
‐ R1およびR2は隣接の窒素原子とともに、任意に置換された、飽和または不飽和の、酸素、窒素または硫黄原子から選ばれるさらなるヘテロ原子を含んでもよい、単環または二環の複素環を形成する
を表す一般式(II)のカルバモイルクロリドと
‐ 任意にアリール基で置換された直鎖または分岐したC1−6アルキル、または
‐ 1−3個の二重結合を含むC2−7のアルケニル基、または
‐ 任意に1またはそれ以上のC1−6アルコキシ、トリフルオロ−C1−6アルコキシ、C1−6アルコキシカルボニル、C1−6アルカノイル、アリール、C1−6アルキルチオ、ハロゲン、またはシアノ基で置換された単環、二環または三環アリール基、または
‐ 任意に置換された単環、二環または三環シクロアルキル基、または
‐ R1およびR2は隣接の窒素原子とともに、任意に置換された、飽和または不飽和の、酸素、窒素または硫黄原子から選ばれるさらなるヘテロ原子を含んでもよい、単環または二環の複素環を形成してもよい
を表す一般式(I)の化合物
トランス4−{2−[4−(2,3−ジクロロフェニル)−ピペラジン−1−イル]−エチル}−N,N−ジメチルカルバモイル−シクロヘキシルアミンの調製
500mlの四つ首フラスコ中にジクロロメタン180ml、40%苛性ソーダ40ml、臭化テトラ−n−ブチルアンモニウム0.54g(0.002mol)およびN,N−ジメチルカルバモイルクロリド3.12g(0.029mol)を加える。混合物を20−25℃の間の温度で30分間撹拌し、ついで6.24g(0.0145mol)のトランス4−{2−[4−(2,3−ジクロロフェニル)−ピペラジン−1−イル]−エチル}−シクロヘキシルアミン二塩酸を加える。混合物を激しく撹拌しながら予め45−50℃に熱したオイルバス中に置き、窒素下で10時間、沸点まで加熱する。ついで反応混合物を室温まで冷却し、相を分離し有機層を3×80mlの水、ついで80mlの10%塩化ナトリウム溶液で洗浄する。溶媒を真空で除去し、得られた残渣をさらに最高50℃の温度で重さが一定になるまで乾燥する。
乾燥重量:5.7g(92%)
融点:212−214℃
トランス4−{2−[4−(2,3−ジクロロフェニル)−ピペラジン−1−イル]−エチル}−N,N−ジメチルカルバモイル−シクロヘキシルアミンの調製
500mlの四つ首フラスコ中にジクロロメタン180ml、40%苛性ソーダ40ml、臭化テトラ−n−ブチルアンモニウム0.54g(0.002mol)およびN,N−ジメチルカルバモイルクロリド3.12g(0.029mol)を加える。混合物を20−25℃の間の温度で30分間撹拌し、ついで6.50g(0.0145mol)のトランス4−{2−[4−(2,3−ジクロロフェニル)−ピペラジン−1−イル]−エチル}−シクロヘキシルアミン二塩酸一水和物を加える。混合物を激しく撹拌しながら予め45−50℃に熱したオイルバス中に置き、窒素下で10時間、沸点まで加熱する。ついで反応混合物を室温まで冷却し、相を分離し有機層を3×80mlの水、ついで80mlの10%塩化ナトリウム溶液で洗浄する。溶媒を真空で除去し、得られた残渣をさらに最高50℃の温度で重さが一定になるまで乾燥する。
乾燥重量:5.7g(92%)
融点:212−214℃
トランスN−{4−{2−[4−(2,3−ジクロロフェニル)−ピペラジン−1−イル]−エチル}−シクロヘキシル}−モルホリン−4−炭酸アミドの調製
500mlの四つ首フラスコ中にジクロロメタン400ml、40%苛性ソーダ40ml、臭化テトラ−n−ブチルアンモニウム1.2g(0.0036mol)およびN,N−ジメチルカルバモイルクロリド11g(0.074mol)を加える。混合物を20−25℃の間の温度で30分間撹拌し、ついで15.5g(0.036mol)のトランス4−{2−[4−(2,3−ジクロロフェニル)−ピペラジン−1−イル]−エチル}−シクロヘキシルアミン二塩酸を加える。混合物を激しく撹拌しながら予め45−50℃に熱したオイルバス中に置き、窒素下で4時間、沸点まで加熱する。ついで反応混合物を室温まで冷却し、相を分離し有機層を3×80mlの水、ついで150mlの10%塩化ナトリウム溶液で洗浄する。溶媒を真空で除去し、得られた残渣をさらに最高50℃の温度で重さが一定になるまで乾燥する。
乾燥重量:15.2g(90%)
融点:203−205℃
Claims (7)
- R1およびR2が独立に、
‐ 任意にアリール基で置換された直鎖または分岐したC1−6アルキル、または
‐ 1−3個の二重結合を含むC2−7のアルケニル基、または
‐ 任意に1またはそれ以上のC1−6アルコキシ、トリフルオロ−C1−6アルコキシ、C1−6アルコキシカルボニル、C1−6アルカノイル、アリール、C1−6アルキルチオ、ハロゲン、またはシアノ基で置換された単環、二環または三環アリール基、または
‐ 任意に置換された単環、二環または三環シクロアルキル基、または
‐ R1およびR2は隣接の窒素原子とともに、任意に置換された、飽和または不飽和の、酸素、窒素または硫黄原子から選ばれるさらなるヘテロ原子を含んでもよい、単環または二環の複素環を形成する
を表す一般式(I)の化合物を
- 相間移動触媒がテトラアルキルアンモニウム塩であることを特徴とする請求項1に記載の方法。
- テトラアルキルアンモニウム塩がハロゲン化テトラ−n−ブチルアンモニウムであることを特徴とする請求項2に記載の方法。
- テトラアルキルアンモニウム塩が臭化テトラアルキルアンモニウムであることを特徴とする請求項3に記載の方法。
- 溶媒が不活性の水と混ざらない溶媒であることを特徴とする請求項1に記載の方法。
- 溶媒がトルエン、ジクロロメタン、クロロベンゼンまたはキシレンであることを特徴とする請求項1に記載の方法。
- 反応が45−50℃の間の温度で行われることを特徴とする請求項1に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0800766A HUP0800766A2 (en) | 2008-12-18 | 2008-12-18 | Process for the preparation of piperazine derivatives |
HUP0800766 | 2008-12-18 | ||
PCT/HU2009/000110 WO2010070371A1 (en) | 2008-12-18 | 2009-12-18 | Process for the preparation of piperazine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012512862A JP2012512862A (ja) | 2012-06-07 |
JP5583689B2 true JP5583689B2 (ja) | 2014-09-03 |
Family
ID=89988675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011541615A Active JP5583689B2 (ja) | 2008-12-18 | 2009-12-18 | ピペラジン誘導体の調製プロセス |
Country Status (9)
Country | Link |
---|---|
US (1) | US8569497B2 (ja) |
EP (1) | EP2367807B1 (ja) |
JP (1) | JP5583689B2 (ja) |
CN (1) | CN102256955B (ja) |
EA (1) | EA019521B1 (ja) |
HK (1) | HK1160847A1 (ja) |
HU (1) | HUP0800766A2 (ja) |
TW (1) | TWI454464B (ja) |
WO (1) | WO2010070371A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
US7875610B2 (en) * | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
EA023972B1 (ru) * | 2008-02-21 | 2016-08-31 | Рихтер Гедеон Нирт. | Стабильный твёрдый препарат карипразина для перорального введения и способ его получения |
MY156288A (en) | 2008-07-16 | 2016-01-29 | Richter Gedeon Nyrt | Pharmaceutical formulations containing dopamine receptor ligands. |
HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
HUP0900790A2 (en) * | 2009-12-17 | 2011-09-28 | Richter Gedeon Nyrt | A new process for the preparation of piperazine and their hydrochloric salts |
US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
CN110872262A (zh) * | 2018-08-29 | 2020-03-10 | 上海科胜药物研发有限公司 | 一种卡利拉嗪的合成方法 |
CN111320593B (zh) * | 2018-12-13 | 2022-04-22 | 江苏恩华药业股份有限公司 | 一种高纯度卡利拉嗪的精制方法 |
US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047406A (en) | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
US4957921A (en) | 1989-12-06 | 1990-09-18 | Warner-Lambert Company | Substituted cyclohexanols as central nervous system agents |
CA2186371A1 (en) | 1994-03-25 | 1995-10-05 | Robert T. Foster | Enhancement of the efficacy of dihydropyridines by deuteration |
US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
WO1997011070A1 (en) | 1995-09-22 | 1997-03-27 | Warner-Lambert Company | Substituted cyclohexylamines as central nervous system agents |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
WO1999050247A1 (en) | 1998-03-31 | 1999-10-07 | Acadia Pharmaceuticals, Inc. | Compounds with activity on muscarinic receptors |
SE9802208D0 (sv) | 1998-06-22 | 1998-06-22 | Astra Pharma Inc | Novel compounds |
US6489341B1 (en) | 1999-06-02 | 2002-12-03 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives |
KR20030074849A (ko) | 2001-02-27 | 2003-09-19 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 양극성 장애의 예방 또는 치료에 사용하기 위한카바메이트 화합물 |
US6566550B2 (en) | 2001-06-21 | 2003-05-20 | Pfizer Inc | Substituted aromatic ethers as inhibitors of glycine transport |
HU227543B1 (en) | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
SE0200301D0 (sv) | 2002-02-01 | 2002-02-01 | Axon Biochemicals Bv | Thio-carbostyril derivative |
US6919342B2 (en) | 2003-06-05 | 2005-07-19 | Abbott Gmbh & Co. Kg | Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
HU227534B1 (en) | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
DE102004047517A1 (de) | 2004-09-28 | 2006-03-30 | Merck Patent Gmbh | Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid |
HUP0500170A3 (en) | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
HU230748B1 (hu) | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
EA017732B1 (ru) | 2007-05-11 | 2013-02-28 | Рихтер Гедеон Нирт. | Сольватная и кристаллическая формы гидрохлорида транс-1{4-[2-[4-(2,3-дихлорфенил)пиперазин-1-ил]этил]циклогексил}-3,3-диметилмочевины, способы их получения и их применение в фармацевтических композициях и способах лечения состояний, для которых необходима модуляция дофаминовых рецепторов |
HUP0700353A2 (en) * | 2007-05-18 | 2008-12-29 | Richter Gedeon Nyrt | Metabolites of (thio)carbamoyl-cyclohexane derivatives |
HUP0700370A2 (en) | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania |
HUP0700369A2 (en) | 2007-05-24 | 2009-04-28 | Richter Gedeon Nyrt | Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia |
AU2008281112A1 (en) | 2007-08-01 | 2009-02-05 | H. Lundbeck A/S | Use of KCNQ potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
US7875610B2 (en) | 2007-12-03 | 2011-01-25 | Richter Gedeon Nyrt. | Pyrimidinyl-piperazines useful as D3/D2 receptor ligands |
EA023972B1 (ru) | 2008-02-21 | 2016-08-31 | Рихтер Гедеон Нирт. | Стабильный твёрдый препарат карипразина для перорального введения и способ его получения |
MY156288A (en) | 2008-07-16 | 2016-01-29 | Richter Gedeon Nyrt | Pharmaceutical formulations containing dopamine receptor ligands. |
HU230067B1 (hu) | 2008-12-17 | 2015-06-29 | Richter Gedeon Nyrt | Új piperazin só és eljárás előállítására |
HUP0800765A2 (en) | 2008-12-18 | 2010-11-29 | Richter Gedeon Nyrt | A new process for the preparation of piperazine derivatives and their hydrochloric salts |
-
2008
- 2008-12-18 HU HU0800766A patent/HUP0800766A2/hu unknown
-
2009
- 2009-12-15 TW TW098142940A patent/TWI454464B/zh active
- 2009-12-18 EA EA201170809A patent/EA019521B1/ru not_active IP Right Cessation
- 2009-12-18 CN CN200980150721.8A patent/CN102256955B/zh active Active
- 2009-12-18 WO PCT/HU2009/000110 patent/WO2010070371A1/en active Application Filing
- 2009-12-18 EP EP09797147A patent/EP2367807B1/en active Active
- 2009-12-18 US US13/140,261 patent/US8569497B2/en active Active
- 2009-12-18 JP JP2011541615A patent/JP5583689B2/ja active Active
-
2012
- 2012-02-08 HK HK12101189.5A patent/HK1160847A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HU0800766D0 (en) | 2009-03-02 |
EP2367807B1 (en) | 2013-02-13 |
TW201035057A (en) | 2010-10-01 |
CN102256955A (zh) | 2011-11-23 |
EA201170809A1 (ru) | 2011-12-30 |
HUP0800766A2 (en) | 2010-11-29 |
TWI454464B (zh) | 2014-10-01 |
US20110269959A1 (en) | 2011-11-03 |
WO2010070371A8 (en) | 2011-04-28 |
EA019521B1 (ru) | 2014-04-30 |
CN102256955B (zh) | 2014-03-12 |
EP2367807A1 (en) | 2011-09-28 |
US8569497B2 (en) | 2013-10-29 |
JP2012512862A (ja) | 2012-06-07 |
HK1160847A1 (en) | 2012-08-17 |
WO2010070371A1 (en) | 2010-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5583689B2 (ja) | ピペラジン誘導体の調製プロセス | |
JP5744751B2 (ja) | ピペラジン化合物およびその塩酸塩の調製プロセス | |
JP4669564B2 (ja) | 2−イミノ−チアゾリジン−4−オン誘導体の製造のための新規な方法 | |
JP2012512861A5 (ja) | ||
JP4938790B2 (ja) | イオン液体触媒を使用するアニリン又はアニリン誘導体の環アルキル化 | |
BG108090A (bg) | Метод за получаване на мезилатни пиперазинови производни | |
CS198297B2 (en) | Method of producing derivatives of urea | |
JPH0570443A (ja) | 2−(2’,4’−ジヒドロキシフエニル)−4,6−ジアリール−s−トリアジンの製造方法 | |
JP7311520B2 (ja) | スルフェントラゾンの合成のための方法 | |
EP3262031A1 (en) | Process for the preparation of vortioxetine | |
US7276637B2 (en) | Synthesis of cyclohexanone derivatives | |
WO2011073705A1 (en) | Novel process for the preparation of piperazine compounds and hydrochloride salts thereof | |
JP4790317B2 (ja) | 10α−[4’−(S,S−ジオキソチオモルホリン−1’−イル)]−10−デオキソ−10−ジヒドロアルテミシニンの製造方法 | |
JPS589103B2 (ja) | テトラミゾ−ル及びその酸付加塩の製造に有用な中間体の製法 | |
WO2015127175A1 (en) | Composition, synthesis, and use of new arylsulfonyl isonitriles | |
JP3996228B2 (ja) | 3−ピペラジニルベンズイソチアゾール類の製造法 | |
EP1438301B1 (en) | Process of production of n-alkyl-2-benzthiazolylsulfeneimides and method of their purification | |
JPH0368569A (ja) | 置換エテン類の製造法 | |
CN110914250B (zh) | 用于合成非罗考昔的新工艺 | |
KR900007628B1 (ko) | 이미다졸 유도체의 제조방법 | |
US2784194A (en) | Phenacylsulfonyl pyridine compounds | |
JPH10195048A (ja) | 3−(ニトロベンゾイル)インドール誘導体の製造法 | |
JP2003073366A (ja) | 1,2−ベンゾイソチアゾリン−3−オン化合物の製造方法 | |
CS232331B1 (cs) | Způsob přípravy tricyklických antidepresiv | |
JPH0527613B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121120 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140228 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140530 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140620 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140716 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5583689 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |